Global Implantable Cardioverter Defibrillator (ICD) Market 2008-2012
DescriptionDescription:
28 January 2010, Pages - 18 The ageing population, coupled with the increasing cases of cardiovascular diseases, and advancement in new innovative technologies, are driving the growth of Implantable Cardioverter Defibrillator (ICD) devices. ICDs are widely being used in Americas and Europe. Further, expansion of ICD therapies across the different Asian countries like China, Japan and India holds a potential growth for the ICD market. Consolidation of the industry through acquisitions and partnerships is also contributing to the growth of the ICD market in the industry. Over the past years, several large competitors have made significant acquisitions to fast-track technology into the market. The market for ICD shows a potential growth due to the increasing number of cardio vascular diseases (due to factors such as smoking, obesity, etc). The awareness of risk of developing cardiovascular problems and availability of the required treatment has enabled access to new technologies and quality products. This results in increase in the number of implants, and favorably influences the market growth. The report by TechNavioTM Insights forecasts the size of the global implantable cardioverter defibrillator (ICD)over the period 2008-2012. It segments the market into three geographic regions: Americas, APAC and EMEA, representing the market size and forecast for each of these regions. Further, it discusses the key market trends, drivers and challenges of the global implantable cardioverter defibrillator market and profiles some of the key vendors of this industry. Special Offer: You can request one free hour of analyst time when you purchase this report. Details provided within the report. Table of ContentsTable of Contents:
1. Introduction 2. Implantable Cardioverter Defibrillator (ICD) Market Size & Forecast 3. Market Segmentation by Geography 3.1 Implantable Cardioverter Defibrillator (ICD) Market in Americas 3.2 Implantable Cardioverter Defibrillator (ICD) Market in EMEA 3.3 Implantable Cardioverter Defibrillator (ICD) Market in APAC 4. Market Trends 5. Growth Drivers 6. Challenges for ICD Industry 7. Implantable Cardioverter Defibrillator (ICD) Vendors 7.1 BIOTRONIK, Inc 7.2 Boston Scientific Corporation 7.3 Medtronic, Inc 7.4 Sorin Group 7.5 St. Jude Medical Inc Other Reports in this Series List of Exhibits Exhibit 2.1: Global Implantable Cardioverter Defibrillator (ICD) Market Size and Forecast 2008-2012 (In $ million) Exhibit 3.1: Market Segmentation of Implantable Cardioverter Defibrillator (ICD) by Geography (2008) Exhibit 3.2: Americas Implantable Cardioverter Defibrillator (ICD) Market Size 2008-2012 (in $ million) Exhibit 3.3: EMEA Implantable Cardioverter Defibrillator (ICD) Market Size 2008-2012 (In $ million) Exhibit 3.4: APAC Implantable Cardioverter Defibrillator (ICD) Market Size 2008-2012 (in $ million) SKU: IRTNTR220 |
|